RNF138 Downregulates Antiviral Innate Immunity by Inhibiting IRF3 Activation

Int J Mol Sci. 2023 Nov 9;24(22):16110. doi: 10.3390/ijms242216110.

Abstract

A viral infection activates the transcription factors IRF3 and NF-κB, which synergistically induces type I interferons (IFNs). Here, we identify the E3 ubiquitin ligase RNF138 as an important negative regulator of virus-triggered IRF3 activation and IFN-β induction. The overexpression of RNF138 inhibited the virus-induced activation of IRF3 and the transcription of the IFNB1 gene, whereas the knockout of RNF138 promoted the virus-induced activation of IRF3 and transcription of the IFNB1 gene. We further found that RNF138 promotes the ubiquitination of PTEN and subsequently inhibits PTEN interactions with IRF3, which is essential for the PTEN-mediated nuclear translocation of IRF3, thereby inhibiting IRF3 import into the nucleus. Our findings suggest that RNF138 negatively regulates virus-triggered signaling by inhibiting the interaction of PTEN with IRF3, and these data provide new insights into the molecular mechanisms of cellular antiviral responses.

Keywords: IRF3; PTEN; RNF138; antiviral natural immunity.

MeSH terms

  • Antiviral Agents / pharmacology
  • Immunity, Innate*
  • Interferon Regulatory Factor-3 / metabolism
  • Interferon-beta* / metabolism
  • NF-kappa B / metabolism
  • Signal Transduction

Substances

  • Interferon-beta
  • NF-kappa B
  • Antiviral Agents
  • Interferon Regulatory Factor-3